The Role of Rho Kinase Inhibitors in Corneal Diseases

Autor: Futterknecht S, Chatzimichail E, Gugleta K, Panos GD, Gatzioufas Z

Publikováno v: Drug Design, Development and Therapy, Vol Volume 18, Pp 97-108 (2024)

Stefan Futterknecht,1,2 Eleftherios Chatzimichail,1 Konstantin Gugleta,1,3 Georgios D Panos,4,5,* Zisis Gatzioufas1,3,* 1Department of Ophthalmology, University Hospital of Basel, Basel, Switzerland; 2Institute of Molecular and Clinical Ophth

Externí odkaz: https://doaj.org/article/24c1267ba79f483cad5f68e764b1ba1d

Efficacy of TNF-Alpha Inhibitors to Control Inflammation and Prevent Secondary Complications in Non-Infectious Uveitis: A Real-Life Experience from Switzerland.

Autor: Fuchs D; Department of Ophthalmology, Cantonal Hospital of Lucerne, Lucerne, Switzerland., Bograd A; Berner Augenklinik, Bern, Switzerland.; Department of Ophthalmology, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.; Department of Ophthalmology, Pallas Klink, Olten, Switzerland., Pfister IB; Berner Augenklinik, Bern, Switzerland., Bächtiger J; Berner Augenklinik, Bern, Switzerland., Spindler J; Berner Augenklinik, Bern, Switzerland.; Department of Ophthalmology University Hospital Zurich, University of Zurich, Zurich, Switzerland., Hoogewoud F; Eye Hospital, FAA, Department of Ophthalmology, University of Lausanne Jules-Gonin, Lausanne, Switzerland., Gugleta K; Department of Ophthalmology, University of Basel, Basel, Switzerland., Böni C; Department of Ophthalmology University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Augenarztpraxis Bremgarten, Bremgarten, Switzerland., Guex-Crosier Y; Eye Hospital, FAA, Department of Ophthalmology, University of Lausanne Jules-Gonin, Lausanne, Switzerland., Garweg JG; Berner Augenklinik, Bern, Switzerland.; Department of Ophthalmology, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland., Tappeiner C; Department of Ophthalmology, Pallas Klink, Olten, Switzerland.; Department of Ophthalmology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.; Department of Ophthalmology, San Raffaele Scientific Institute, University Vita-Salute, Milan, Italy.; Medical Faculty, University of Bern, Bern, Switzerland.

Publikováno v: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Oct; Vol. 32 (8), pp. 1585-1590. Date of Electronic Publication: 2023 Oct 05.

Real-world outcomes of micropulse transscleral laser therapy in glaucoma patients: Efficacy of initial and repeated treatment, transient intraocular pressure spikes.

Autor: Dervos T; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland., Fortuna LL; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland., Gugleta K; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland., Scholl HPN; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland.; Institute of Molecular and Clinical Ophthalmology Basel (IOB), Switzerland., Gatzioufas Z; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland., Hasler PW; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland., Arabin V; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland., Enz TJ; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland.

Publikováno v: Heliyon [Heliyon] 2024 Aug 10; Vol. 10 (16), pp. e36019. Date of Electronic Publication: 2024 Aug 10 (Print Publication: 2024).

Swiss Multicenter Ab Interno XEN45 Gel Stent Study: 2-Year Real-World Data.

Autor: Papazoglou A; Department of Ophthalmology, Cantonal Hospital Aarau, Aarau, Switzerland. anthia.papazoglou@gmail.com.; Medical Faculty, University of Zurich, Zurich, Switzerland. anthia.papazoglou@gmail.com., Höhn R; Department of Ophthalmology, University Hospital Bern, Bern, Switzerland.; Eyeparc Eyeclinic, Bern, Switzerland., Schawkat M; Department of Ophthalmology, University Hospital Bern, Bern, Switzerland., Tappeiner C; Department of Ophthalmology, University Hospital Bern, Bern, Switzerland.; Department of Ophthalmology, Pallas Kliniken, Olten, Switzerland.; Medical Faculty, University of Bern, Bern, Switzerland.; Department of Ophthalmology, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Iliev M; Department of Ophthalmology, University Hospital Bern, Bern, Switzerland.; Medical Faculty, University of Bern, Bern, Switzerland., Gugleta K; Department of Ophthalmology, University of Basel and University Hospital, Basel, Switzerland., Saletta G; Department of Ophthalmology, University of Basel and University Hospital, Basel, Switzerland., Wiencierz A; Department of Clinical Research, University of Basel and University Hospital, Basel, Switzerland., Wagels B; Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Todorova MG; Medical Faculty, University of Zurich, Zurich, Switzerland.; Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Krzyzanowska I; Medical Faculty, University of Zurich, Zurich, Switzerland.; Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland., Töteberg-Harms M; Medical Faculty, University of Zurich, Zurich, Switzerland.; Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland.; Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA, USA., Tschopp M; Department of Ophthalmology, Cantonal Hospital Aarau, Aarau, Switzerland. markus.tschopp@windowslive.com.; Medical Faculty, University of Bern, Bern, Switzerland. markus.tschopp@windowslive.com.

Publikováno v: Ophthalmology and therapy [Ophthalmol Ther] 2024 Jun; Vol. 13 (6), pp. 1513-1525. Date of Electronic Publication: 2024 Apr 06.

Visual evoked potentials in multiple sclerosis: P100 latency and visual pathway damage including the lateral geniculate nucleus.

Autor: Papadopoulou A; Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland; Department of Clinical Research, University of Basel, Switzerland; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, University of Basel, Basel, Switzerland; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland., Pfister A; Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland., Tsagkas C; Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, University of Basel, Basel, Switzerland; Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), Bethesda, MD, USA., Gaetano L; Novartis AG, Basel, Switzerland., Sellathurai S; Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland; Department of Clinical Research, University of Basel, Switzerland; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, University of Basel, Basel, Switzerland; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland., D'Souza M; Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland; Neurostatus AG, University Hospital of Basel, Basel, Switzerland., Cerdá-Fuertes N; Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland; Department of Clinical Research, University of Basel, Switzerland; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, University of Basel, Basel, Switzerland; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland; Neurostatus AG, University Hospital of Basel, Basel, Switzerland., Gugleta K; University Eye Clinic Basel, University Hospital Basel and University of Basel, Basel, Switzerland., Descoteaux M; University of Sherbrooke, QC, Canada., Chakravarty MM; Douglas Mental Health University Institute, Departments of Psychiatry and Biomedical Engineering (M.M.C.), McGill University, Montreal, University of Sherbrooke (M.D.), Canada., Fuhr P; Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland; Department of Clinical Research, University of Basel, Switzerland., Kappos L; Department of Clinical Research, University of Basel, Switzerland; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, University of Basel, Basel, Switzerland; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland., Granziera C; Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland; Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, University of Basel, Basel, Switzerland; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland., Magon S; Pharma Research and Early Development, Neuroscience and Rare Diseases Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Sprenger T; University Hospital Zurich, Zurich, Switzerland., Hardmeier M; Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland. Electronic address: martin.hardmeier@usb.ch.

Publikováno v: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology [Clin Neurophysiol] 2024 May; Vol. 161, pp. 122-132. Date of Electronic Publication: 2024 Feb 20.